Signal Explorer

Advance Notice Requirement Disclosed

Fda Aligned Protocol Amended Enrollment Ahead Of Schedule Interim Data Positive Investigational Device Exemption Granted Termination For Material Breach Clause Expanded Access Program Active

Accelerated Approval

Clinical Hold Lead Asset Progress

Net Loss Reported Rsu Psu Vesting Schedule Disclosed Cash Flow Statement Investing Activities Codm Segment Reporting Disclosure Depreciation Expense Composition Disclosure Warrant Valued Black Scholes Ipo Net Proceeds Disclosure Fair Value Hierarchy Disclosure Ipo Or Capital Raising Completion Segment Aggregation Disclosure Financing Activities Cash Flow Disclosure Use Of Proceeds Disclosure Institutional Investment Shares Outstanding Disclosure Stock Option Grant Disclosed

Crl Received

Clinical Trial Result Clinical Hold

Breakthrough Therapy Granted Fda Aligned Orphan Status Granted Fast Track Granted Fast Track Designation Received Protocol Amended Ce Mark Received Interim Data Positive

Orphan Drug Designation Clinical Hold Active

Clinical Trial Result Combination Therapy Mentioned Clinical Hold Lead Asset Progress Regulatory Designation Only

Ipo Net Proceeds Disclosure Ipo Or Capital Raising Completion

Warrant Valued Black Scholes Net Loss Reported Cash Flow Statement Investing Activities Depreciation Expense Composition Disclosure Operating Lease Rent Expense Disclosed Ipo Or Capital Raising Completion Financing Activities Cash Flow Disclosure Convertible Notes Conversion Terms Disclosed Stock Option Grant Disclosed Equity Compensation Accounting Policy Shares Outstanding Disclosure Institutional Investment Kol Endorsement

Combination Therapy Mentioned Lead Asset Progress